Pharmaron Holds Second Symposium on Chemistry for Life Science

March 1, 2019  – Pharmaron held its second symposium on Chemistry for Life Science at its Hoddesdon, UK site. The symposium included six presentations covering the latest updates in drug discovery and synthetic chemistry.

Distinguished Symposium Speakers:

  • Dr. Roland Bürli, AstraZeneca, United Kingdom
    In Search of New Functions of Arsenic Methyl Transferase
  • Prof. Alois Fürstner, Max-Planck-Institut für Kohlenforschung, Germany
    Catalysis in Total Synthesis
  • Dr. Tom Heightman, Astex Therapeutics, United Kingdom
    Fragment Based Drug Discovery for Challenging Targets
  • Dr. Emma Parmee, MSD, United States
    New Directions in Drug Discovery at MSD: Expanding Exploration of Chemical Space
  • Prof. Samir Zard, Ecole Polytechnique, France
    Radicals in Action: New Perspectives for Organic Synthesis and Medicinal Chemistry
  • Prof. Yong-Gui Zhou, Dalian Institute of Chemical Physics, China
    Asymmetric Hydrogenation of Heteroaromatics

In addition, ten students were selected to display their research in a poster competition held during the afternoon break. Posters were reviewed for novelty of the chemistry and quantity of work. The winning poster was by Xiangyu Zhang, from University College of London. His poster research title is “Total Synthesis of (+) Vallesamidine and Progress on (+) Strempeliopine.”

"Innovation has been one of the key drivers for Pharmaron’s business to grow at a high pace, with high quality. Our company’s learning culture helps us to develop in a sustainable manner.  Annual symposia organized by Pharmaron across the entire organization provide fora for our scientists to closely interact with scientific and technological leaders from around the world, to discuss new discoveries, exchange novel ideas and stimulate creative thoughts. This symposium reflects our long-term commitment to excellence in science,” said Dr. Boliang Lou, Chairman and CEO.